Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Diabetes Health Center

Font Size

Diabetics Get Kidney Protection From ARBs

WebMD Health News
Reviewed by Gary D. Vogin, MD

May 20, 2001 (San Francisco) -- Five million Americans have both type 2 diabetes and high blood pressure, a one-two punch that can seriously damage the kidneys and the heart. Now results from three landmark studies of almost 4,000 diabetic patients suggest that a specific class of blood pressure drugs called angiotensin receptor blockers, or ARBs, can protect kidneys and reduce the need for kidney dialysis or transplant.

Results from all three studies were released Saturday at the annual meeting of the American Society of Hypertension.

Among the findings were the following:

  • A 28% reduction in the risk of kidney failure among diabetics with established kidney disease.
  • A slowing of the progression of kidney disease.
  • A 20% reduction in death.

None of the studies evaluated how well the drugs protect the heart.

Nonetheless, in an impassioned presentation to several thousand high blood pressure experts packed into a hotel ballroom, one of the researchers, Hans-Henrik Parving, MD, DMSc, shouted "I call this victory!" Parving is chief physician at the Steno Diabetes Center in Gentofte, Denmark.

"There is an epidemic of progressive [kidney] disease in the United States, and it is due to type 2 diabetes," says Barry M. Brenner, MD, one of the study authors. "If one lives for 15 years with type 2 diabetes, the number of complications looms very large." Brenner is a professor at Harvard Medical School.

Avapro, a drug marketed by Bristol-Myers Squibb and Sanofi-Sythelabo, was the subject of two linked studies. In the first study, researchers tested the drug's ability to slow the progression of diabetic kidney disease in people who have very early signs of kidney failure. The second study tested Avapro in diabetics with established kidney disease to see if it could prevent progression to kidney failure or death. The drug companies funded the studies.

In both studies, the drug protected the kidneys, says Edmund J. Lewis, MD, who lead the study of more than 1,700 diabetics with established kidney disease. Lewis is a professor at Rush Medical College in Chicago.

The third study evaluated another ARB called Cozaar. Merck is the maker of Cozaar and paid for the study. Brenner, who was the lead investigator of this study, tells WebMD that Cozaar also was effective at slowing kidney disease. This study evaluated more than 1,500 diabetics.

1 | 2 | 3

Today on WebMD

Diabetic tools
Symptoms, diagnosis, treatment, and more.
woman flexing muscles
10 strength training exercises.
Blood sugar test
12 practical tips.
Tom Hanks
Stars living with type 1 or type 2.
kenneth fujioka, md
Can Vinegar Treat Diabetes
Middle aged person
Home Healthcare

Prediabetes How to Prevent Type 2 Diabetes
type 2 diabetes
food fitness planner